The clinical relevance of our data showing a prominent increase in overall expression of EPOR in the brains of APP/PS1 mice is reflected by the studies showing increased EPOR in hippocampal and cortical astrocytes in patients with mild cognitive impairment and sporadic AD [51]. The gene discussed is APP; the disease is Cognitive impairment.